Applications of protein microarrays for biomarker discovery

被引:58
作者
Ramachandran, Niroshan [1 ]
Srivastava, Sanjeeva [1 ]
LaBaer, Joshua [1 ]
机构
[1] Harvard Univ, Sch Med, Harvard Inst Prote, Dept Biol Chem & Mol Pharmacol, Cambridge, MA 02141 USA
基金
加拿大自然科学与工程研究理事会;
关键词
Autoantibodies; Autoantigens; Antibody array; Biochip; Biomarkers;
D O I
10.1002/prca.200800032
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The search for new biomarkers for diagnosis, prognosis, and therapeutic monitoring of diseases continues in earnest despite dwindling success at finding novel reliable markers. Some of the current markers in clinical use do not provide optimal sensitivity and specificity with the prostate cancer antigen (PSA) being one of many such examples. The emergence of proteomic techniques and systems approaches to study disease pathophysiology has rekindled the quest for new biomarkers. In particular the use of protein microarrays has surged as a powerful tool for large-scale testing of biological samples. Approximately half the reports on protein microarrays have been published in the last two years especially in the area of biomarker discovery. In this review, we will discuss the application of protein microarray technologies that offer unique opportunities to find novel biomarkers.
引用
收藏
页码:1444 / 1459
页数:16
相关论文
共 90 条
[1]   Dissection of signaling pathways in fourteen breast cancer cell lines using reverse-phase protein lysate microarray [J].
Akkiprik, Mustafa ;
Nicorici, Daniel ;
Cogdell, David ;
Jia, Yu Jack ;
Hategan, Andrea ;
Tabus, Ioan ;
Yli-Harja, Olli ;
Yu, Dihua ;
Sahin, Aysegul ;
Zhang, Wei .
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2006, 5 (06) :543-551
[2]   The sentinel within: Exploiting the immune system for cancer biomarkers [J].
Anderson, KS ;
LaBaer, J .
JOURNAL OF PROTEOME RESEARCH, 2005, 4 (04) :1123-1133
[3]   Telomere 3′ overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells [J].
Aoki, Hiroshi ;
Iwado, Eiji ;
Eller, Mark S. ;
Kondo, Yasuko ;
Fujiwara, Keishi ;
Li, Guang-Zhi ;
Hess, Kenneth R. ;
Siwak, Doris R. ;
Sawaya, Raymond ;
Mills, Gordon B. ;
Gilchrest, Barbara A. ;
Kondo, Seiji .
FASEB JOURNAL, 2007, 21 (11) :2918-2930
[4]   In biomarkers we trust? [J].
Baker, M .
NATURE BIOTECHNOLOGY, 2005, 23 (03) :297-304
[5]   Antibody evolution beyond Nature [J].
Borrebaeck, CAK ;
Ohlin, M .
NATURE BIOTECHNOLOGY, 2002, 20 (12) :1189-1190
[6]   Microarrays of tumor cell derived proteins uncover a distinct pattern of prostate cancer serum immunoreactivity [J].
Bouwman, K ;
Qiu, J ;
Zhou, HP ;
Schotanus, M ;
Mangold, LA ;
Vogt, R ;
Erlandson, E ;
Trenkle, J ;
Partin, AW ;
Misek, D ;
Omenn, GS ;
Haab, BB ;
Hanash, S .
PROTEOMICS, 2003, 3 (11) :2200-2207
[7]   A human cDNA library for high-throughput protein expression screening [J].
Büssow, K ;
Nordhoff, E ;
Lübbert, C ;
Lehrach, H ;
Walter, G .
GENOMICS, 2000, 65 (01) :1-8
[8]   Clinical proteomics: From biomarker discovery and cell signaling profiles to individualized personal therapy [J].
Calvo, KR ;
Liotta, LA ;
Petricoin, EF .
BIOSCIENCE REPORTS, 2005, 25 (1-2) :107-125
[9]   Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays [J].
Carlsson, Anders ;
Wingren, Christer ;
Ingvarsson, Johan ;
Ellmark, Peter ;
Baldertorp, Bo ;
Ferno, Marten ;
Olsson, Hakan ;
Borrebaeck, Carl A. K. .
EUROPEAN JOURNAL OF CANCER, 2008, 44 (03) :472-480
[10]  
Charboneau Lu, 2002, Briefings in Functional Genomics & Proteomics, V1, P305, DOI 10.1093/bfgp/1.3.305